Nykredit A S Purchases New Holdings in GE HealthCare Technologies Inc. $GEHC

Nykredit A S acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 100,673 shares of the company’s stock, valued at approximately $6,405,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of GEHC. Godfrey Financial Associates Inc. bought a new stake in shares of GE HealthCare Technologies in the 4th quarter worth approximately $27,000. Transamerica Financial Advisors LLC increased its position in GE HealthCare Technologies by 331.6% during the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after buying an additional 262 shares in the last quarter. Physician Wealth Advisors Inc. raised its stake in GE HealthCare Technologies by 60.4% during the first quarter. Physician Wealth Advisors Inc. now owns 433 shares of the company’s stock valued at $31,000 after buying an additional 163 shares during the last quarter. MV Capital Management Inc. bought a new stake in GE HealthCare Technologies in the fourth quarter worth $33,000. Finally, Hilton Head Capital Partners LLC bought a new stake in GE HealthCare Technologies in the fourth quarter worth $34,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ:GEHC opened at $68.86 on Monday. The stock’s 50-day simple moving average is $68.29 and its two-hundred day simple moving average is $68.93. The stock has a market capitalization of $31.10 billion, a price-to-earnings ratio of 15.79, a PEG ratio of 1.82 and a beta of 0.70. GE HealthCare Technologies Inc. has a 52-week low of $58.75 and a 52-week high of $89.77. The company has a debt-to-equity ratio of 0.92, a quick ratio of 0.97 and a current ratio of 1.26.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $1.13 EPS for the quarter, topping the consensus estimate of $1.04 by $0.09. The firm had revenue of $5.29 billion during the quarter, compared to analyst estimates of $5.26 billion. GE HealthCare Technologies had a return on equity of 20.12% and a net margin of 9.33%.GE HealthCare Technologies’s revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the business posted $1.06 EPS. Analysts expect that GE HealthCare Technologies Inc. will post 4.93 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Friday, July 24th were paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend was Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.21%.

Analysts Set New Price Targets

Several brokerages recently commented on GEHC. Piper Sandler reissued a “buy” rating on shares of GE HealthCare Technologies in a research report on Wednesday, July 29th. BMO Capital Markets started coverage on shares of GE HealthCare Technologies in a report on Wednesday, July 8th. They issued a “market perform” rating and a $70.00 target price for the company. Oppenheimer reiterated an “outperform” rating on shares of GE HealthCare Technologies in a research note on Thursday, July 30th. The Goldman Sachs Group reiterated a “neutral” rating on shares of GE HealthCare Technologies in a report on Monday, June 8th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of GE HealthCare Technologies in a research report on Wednesday, August 12th. Ten investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $77.73.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.